Updated:
Cantheon Capital
Cantheon Capital provides corporate advisory, capital funding, and scientific advice to cannabinoid and psychedelic biotechs.
Cantheon Capital
Cantheon Capital provides corporate advisory, capital funding, and scientific advice to cannabinoid and psychedelic biotechs. The firm focuses on early and mid-stage companies navigating clinical trials. It is based in Singapore.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Dallas
Corporate office
Dallas, TX, United States
Frequently asked questions
What is Cantheon Capital's primary investment strategy?
Cantheon Capital focuses on early-stage private equity investments. This means the firm typically provides capital to companies that are still in their initial phases of product development, market entry, or first revenue generation. The firm's own materials point only to an 'Early Stage' strategy without further public breakdown by sector or geography.
Where is Cantheon Capital based and where does it invest?
The firm is headquartered in Dallas, Texas. Its website does not specify any additional offices. The geographic scope of its investments is not publicly disclosed, though its single-office presence in Dallas suggests a strong regional tie to the Texas market.
Who are the key investment decision-makers at Cantheon Capital?
The principals and investment committee members of Cantheon Capital are not publicly identified. The firm's website and available public records do not list the names, titles, or professional backgrounds of any managing partners, principals, or deal leads.
How large is Cantheon Capital in terms of assets under management?
Cantheon Capital does not publicly disclose its assets under management. No regulatory filings or credible media reports have published an AUM figure for the firm. Without such a source, the firm's scale of operations remains private.
Does Cantheon Capital disclose any named portfolio companies?
No portfolio company names are publicly listed by Cantheon Capital. A review of the firm's website and professional network profiles reveals no disclosed investments, making it impossible to characterize the firm's track record or specific sector expertise from public data.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: